Ls Investment Advisors, LLC Pfizer Inc Transaction History

Ls Investment Advisors, LLC

$656 Million
Q3 2024

A detailed history of Ls Investment Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ls Investment Advisors, LLC holds 137,416 shares of PFE stock, worth $3.45 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

137,416

Previous 138,524 0.8%

Holding current value

$3.45 Million

Previous $3.88 Million 2.61%

% of portfolio

0.61%

Previous 0.62%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$27.7 - $31.39 $30,691 - $34,780	-1,108 Reduced 0.8%	137,416 $3.98 Million
Q2 2024 Jul 26, 2024	BUY	$25.26 - $29.6 $314,284 - $368,283	12,442 Added 9.87%	138,524 $3.88 Million
Q1 2024 Apr 30, 2024	SELL	$25.89 - $29.73 $193,993 - $222,766	-7,493 Reduced 5.61%	126,082 $3.5 Million
Q4 2023 Jan 12, 2024	BUY	$26.13 - $33.94 $36,216 - $47,040	1,386 Added 1.05%	133,575 $3.85 Million
Q3 2023 Oct 18, 2023	SELL	$32.09 - $37.51 $490,367 - $573,190	-15,281 Reduced 10.36%	132,189 $4.38 Million
Q2 2023 Jul 20, 2023	SELL	$36.12 - $41.79 $1.22 Million - $1.41 Million	-33,707 Reduced 18.6%	147,470 $5.41 Million
Q1 2023 Apr 26, 2023	SELL	$39.39 - $51.28 $1.02 Million - $1.33 Million	-25,871 Reduced 12.5%	181,177 $7.39 Million
Q4 2022 Jan 20, 2023	SELL	$41.75 - $54.5 $585,126 - $763,817	-14,015 Reduced 6.34%	207,048 $0
Q3 2022 Oct 28, 2022	BUY	$43.76 - $53.42 $303,300 - $370,254	6,931 Added 3.24%	221,063 $9.67 Million
Q2 2022 Jul 25, 2022	BUY	$46.53 - $55.17 $18,612 - $22,068	400 Added 0.19%	214,132 $11.2 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $103,623 - $128,402	-2,265 Reduced 1.05%	213,732 $11.1 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $1.95 Million - $2.89 Million	-47,137 Reduced 17.91%	215,997 $12.8 Million
Q3 2021 Oct 21, 2021	BUY	$39.25 - $50.42 $100,362 - $128,923	2,557 Added 0.98%	263,134 $11.3 Million
Q2 2021 Aug 11, 2021	SELL	$35.91 - $40.68 $4.1 Million - $4.64 Million	-114,097 Reduced 30.45%	260,577 $10.2 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $719,465 - $811,412	-21,483 Reduced 5.42%	374,674 $13.6 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $334,432 - $425,259	-9,992 Reduced 2.46%	396,157 $14.6 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $228,917 - $268,572	7,210 Added 1.81%	406,149 $14.9 Million
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $2.11 Million - $2.56 Million	70,058 Added 21.3%	398,939 $13 Million
Q1 2020 Apr 20, 2020	SELL	$27.03 - $38.62 $202,860 - $289,843	-7,505 Reduced 2.23%	328,881 $10.7 Million
Q4 2019 Jan 31, 2020	BUY	$32.92 - $37.36 $29,858 - $33,885	907 Added 0.27%	336,386 $13.2 Million
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $594,859 - $771,358	-18,309 Reduced 5.18%	335,479 $12.1 Million
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $105,429 - $118,373	-2,851 Reduced 0.8%	353,788 $15.3 Million
Q1 2019 Apr 25, 2019	SELL	$37.5 - $41.2 $303,300 - $333,225	-8,088 Reduced 2.22%	356,639 $15.1 Million
Q4 2018 Feb 01, 2019	SELL	$38.47 - $43.86 $2.19 Million - $2.5 Million	-56,966 Reduced 13.51%	364,727 $15.9 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $355,041 - $430,643	-10,300 Reduced 2.38%	421,693 $18.6 Million
Q2 2018 Jul 20, 2018	SELL	$32.98 - $35.16 $202,794 - $216,198	-6,149 Reduced 1.4%	431,993 $15.7 Million
Q1 2018 May 08, 2018	SELL	$31.91 - $37.02 $38,228 - $44,349	-1,198 Reduced 0.27%	438,142 $15.6 Million
Q4 2017 Feb 07, 2018	SELL	$33.26 - $35.29 $356,846 - $378,626	-10,729 Reduced 2.38%	439,340 $15.9 Million
Q3 2017 Oct 19, 2017	BUY	$31.0 - $34.15 $14 Million - $15.4 Million	450,069	450,069 $16.1 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ls Investment Advisors, LLC with notifications on news.

Account

Ls Investment Advisors, LLC Pfizer Inc Transaction History